Association of Low-Dose Ketamine and Ketamine–Midazolam Administration with Postpartum Depressive Symptoms, Postoperative Pain, and Adverse Events in Cesarean Deliveries Under Spinal Anesthesia

Background and Objectives: To evaluate the associations of low-dose ketamine administered alone or with midazolam after umbilical cord clamping with postpartum depressive symptoms, postoperative pain, and intraoperative adverse events in patients undergoing cesarean delivery under spinal anesthesia. Materials and Methods: In this prospective, nonrandomized, controlled observational cohort study, 300 patients were classified into three groups according to the treatment received during routine clinical care, which was determined by their pain and anxiety status after umbilical cord clamping. Patients with pain but no anxiety received intravenous ketamine (0.5 mg/kg); those with both pain and anxiety received ketamine (0.5 mg/kg) plus midazolam (0.01 mg/kg); and those with neither received no additional medication. Each group included 100 patients. Edinburgh Postnatal Depression Scale (EPDS) scores were assessed preoperatively and at postpartum weeks 1, 2, and 4. Postoperative pain was assessed using visual analog scale (VAS) scores at 2, 4, 12, and 24 h. Time to first rescue analgesic requirement and intraoperative adverse events were recorded. Results: At postpartum week 4, EPDS scores (primary outcome) differed between groups, with lower median scores in both treatment groups than in the control group (overall comparison, p = 0.032); in models adjusted for preoperative EPDS score, both treatment groups had lower EPDS scores than the control group. Positive EPDS screening (score ≥ 11) occurred in 15% of the ketamine group, 17% of the ketamine–midazolam group, and 30% of the control group (p = 0.017). The group × time interaction for repeated EPDS scores was significant (p = 0.0055). Compared with controls, both treatment groups had lower VAS scores at 2 and 4 h and a longer time to first rescue analgesic requirement (all overall comparisons, p < 0.001); these associations persisted after adjustment for procedure duration. At 12 and 24 h, a significant pairwise difference from the control group was observed only for ketamine alone. Hallucinations occurred in 32%, 18%, and 2% of patients in the ketamine, ketamine–midazolam, and control groups, respectively (p < 0.001). Other adverse events were numerically less frequent with ketamine–midazolam than with ketamine alone, but the pairwise differences were not statistically significant. Conclusions: Low-dose ketamine administered after umbilical cord clamping, either alone or with midazolam, was associated with lower postpartum depressive symptom scores and a lower rate of positive EPDS screening in adjusted analyses, as well as lower early postoperative pain scores and a longer time to first rescue analgesic requirement. Although adverse events were numerically less frequent with ketamine–midazolam than with ketamine alone, this study did not establish a statistically significant tolerability advantage. Given the nonrandomized, symptom-based treatment selection and potential confounding by indication, these findings should be interpreted as preliminary associations that require confirmation in randomized controlled trials of efficacy and safety before clinical recommendations can be made.

Authors

Institutions

Publication Details

Journal
Medicina
Published
2026-11-13
DOI
https://doi.org/10.3390/medicina62112228
Primary Topic
Anesthesia and Pain Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association of Low-Dose Ketamine and Ketamine–Midazolam Administration with Postpartum Depressive Symptoms, Postoperative Pain, and Adverse Events in Cesarean Deliveries Under Spinal Anesthesia

Neslihan Altunkaya, Nurçin Gülhaş, Esra Porgalı Zayman, Duygu Demiröz Aslan et al.
1 links
Medicina
Anesthesia and Pain Management
article

Association of Low-Dose Ketamine and Ketamine–Midazolam Administration with Postpartum Depressive Symptoms, Postoperative Pain, and Adverse Events in Cesarean Deliveries Under Spinal Anesthesia

Neslihan Altunkaya, Nurçin Gülhaş, Esra Porgalı Zayman, Duygu Demiröz Aslan, Zeynep Küçükakçalı, Ercan Yılmaz, Muharrem Uçar, Feti Ahmet ENGİN, Beyza ENGİN, Emre Arikan
article en

Abstract

Background and Objectives: To evaluate the associations of low-dose ketamine administered alone or with midazolam after umbilical cord clamping with postpartum depressive symptoms, postoperative pain, and intraoperative adverse events in patients undergoing cesarean delivery under spinal anesthesia. Materials and Methods: In this prospective, nonrandomized, controlled observational cohort study, 300 patients were classified into three groups according to the treatment received during routine clinical care, which was determined by their pain and anxiety status after umbilical cord clamping. Patients with pain but no anxiety received intravenous ketamine (0.5 mg/kg); those with both pain and anxiety received ketamine (0.5 mg/kg) plus midazolam (0.01 mg/kg); and those with neither received no additional medication. Each group included 100 patients. Edinburgh Postnatal Depression Scale (EPDS) scores were assessed preoperatively and at postpartum weeks 1, 2, and 4. Postoperative pain was assessed using visual analog scale (VAS) scores at 2, 4, 12, and 24 h. Time to first rescue analgesic requirement and intraoperative adverse events were recorded. Results: At postpartum week 4, EPDS scores (primary outcome) differed between groups, with lower median scores in both treatment groups than in the control group (overall comparison, p = 0.032); in models adjusted for preoperative EPDS score, both treatment groups had lower EPDS scores than the control group. Positive EPDS screening (score ≥ 11) occurred in 15% of the ketamine group, 17% of the ketamine–midazolam group, and 30% of the control group (p = 0.017). The group × time interaction for repeated EPDS scores was significant (p = 0.0055). Compared with controls, both treatment groups had lower VAS scores at 2 and 4 h and a longer time to first rescue analgesic requirement (all overall comparisons, p < 0.001); these associations persisted after adjustment for procedure duration. At 12 and 24 h, a significant pairwise difference from the control group was observed only for ketamine alone. Hallucinations occurred in 32%, 18%, and 2% of patients in the ketamine, ketamine–midazolam, and control groups, respectively (p < 0.001). Other adverse events were numerically less frequent with ketamine–midazolam than with ketamine alone, but the pairwise differences were not statistically significant. Conclusions: Low-dose ketamine administered after umbilical cord clamping, either alone or with midazolam, was associated with lower postpartum depressive symptom scores and a lower rate of positive EPDS screening in adjusted analyses, as well as lower early postoperative pain scores and a longer time to first rescue analgesic requirement. Although adverse events were numerically less frequent with ketamine–midazolam than with ketamine alone, this study did not establish a statistically significant tolerability advantage. Given the nonrandomized, symptom-based treatment selection and potential confounding by indication, these findings should be interpreted as preliminary associations that require confirmation in randomized controlled trials of efficacy and safety before clinical recommendations can be made.

MedicinaVol. 62(11)
Inonu University (TR)
Good health and well-being
Anesthesia and Pain Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon